Wound Infections Clinical Trial
Official title:
Antimicrobial Coated Sutures in Paediatric Surgery
Verified date | February 2015 |
Source | University of Oulu |
Contact | n/a |
Is FDA regulated | No |
Health authority | Finland: Ethics Committee |
Study type | Interventional |
The purpose of this study is to determine if suture material coated by antimicrobial agent
triclosan would decrease the incidence of surgical site infections (SSIs) in paediatric
surgery compared to ordinary sutures.
1500 children (age form 4 weeks to 18 years) coming for general pediatric surgery to the
Oulu University Hospital are randomised to have sutures coated with triclosan (Vicryl Plus,
Monocryl Plus) or ordinary sutures. The occurrence of SSIs is monitored by email
questionnaires to the parents on days 10 and 30. The diagnosis of SSIs are made along CDC
criteria.
Status | Completed |
Enrollment | 1635 |
Est. completion date | January 2015 |
Est. primary completion date | January 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | N/A to 18 Years |
Eligibility |
Inclusion Criteria: - any general surgery during childhood where melting sutures will be used Exclusion Criteria: - wound infection as a cause for surgery |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
Finland | Oulu University Hospital/ Paediatric Surgery | Oulu |
Lead Sponsor | Collaborator |
---|---|
University of Oulu |
Finland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | occurrence of surgical site infections | 30 days | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02578745 -
Prophylactic Incisional Care in Obese Women at Cesarean
|
N/A | |
Withdrawn |
NCT00463762 -
Cefoperazone/Sulbactam In The Treatment Of Serious Intra-Abdominal And Hepatobiliary Infections.
|
Phase 4 | |
Completed |
NCT00061633 -
Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)
|
Phase 2 | |
Terminated |
NCT00651131 -
Cubicin(R) for Complicated Post-surgical Wound Infections
|
Phase 4 | |
Completed |
NCT01700803 -
Povidone Iodine and Cesarean Section Wound Infections
|
Phase 3 | |
Completed |
NCT01049971 -
REDWIL: Reduction of Wound Infections in Laparoscopic Colon Resections by Wound Protectors
|
N/A |